Trials / Completed
CompletedNCT01260311
Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder
Post Marketing Surveillance To Assess The Safety And Efficacy Of Fesoterodine (Toviaz) On Filipino Patients Diagnosed With Over-Active Bladder
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 508 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational study and will determine the safety profile of fesoterodine in Filipino patients prescribed the drug. This is in compliance with the requirements of the Philippine Food and Drug Administration.
Detailed description
Sampling method is not applicable in this study. Only patients prescribed Fesoterodine will be enrolled.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fesoterodine | Any dose of Fesoterodine |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2010-12-15
- Last updated
- 2014-09-11
- Results posted
- 2014-09-11
Locations
37 sites across 1 country: Philippines
Source: ClinicalTrials.gov record NCT01260311. Inclusion in this directory is not an endorsement.